Gene expression induced by Toll-like receptors in macrophages requires the transcription factor NFAT5 by Buxadé, María et al.
Article
The Rockefeller University Press $30.00
J. Exp. Med. Vol. 209 No. 2 379-393
www.jem.org/cgi/doi/10.1084/jem.20111569
379
Toll-like receptors (TLRs) belong to a large 
group of sensors specialized in recognizing spe-
cific molecular patterns of pathogens and are 
expressed by sentinel cells of the immune system 
such as dendritic cells and macrophages (West 
et al., 2006; Kawai and Akira, 2010). Upon rec-
ognition of specific ligands, TLRs initiate intra-
cellular signaling cascades that induce a broad 
gene expression program that regulates the de-
fense against pathogens and stimulates adaptive 
immune responses (Jenner and Young, 2005; 
West et al., 2006; O’Neill and Bowie, 2007). 
The different TLRs ensure an effective response 
against a wide variety of microbial pathogens 
by inducing a common set of gene products 
with general antimicrobial and immunomodu-
latory properties (Jenner and Young, 2005). 
This is accomplished through the shared use 
of core signaling pathways in which mitogen-
activated protein (MAP) kinases (p38, JNK, and 
ERK1/2), the inhibitor of B kinase (IKK) 
–NF-B axis, and IFN regulatory factor (IRF) 
transcription factors are prominent players (Dong 
et al., 2002; Honda and Taniguchi, 2006; West 
et al., 2006). In addition, TLRs need precise reg-
ulatory mechanisms to adjust the patterns of 
genes expressed and their magnitude of induc-
tion to variables such as the type of ligand, the 
transient or persistent nature of the stimulation, 
the dose of that stimulus, or the effect of toler-
ization (Foster et al., 2007; Litvak et al., 2009).
Specificity and fine tuning of gene expres-
sion downstream TLRs are achieved through 
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Toll-like receptors (TLRs) engage networks of transcriptional regulators to induce genes 
essential for antimicrobial immunity. We report that NFAT5, previously characterized as  
an osmostress responsive factor, regulates the expression of multiple TLR-induced genes in 
macrophages independently of osmotic stress. NFAT5 was essential for the induction of the 
key antimicrobial gene Nos2 (inducible nitric oxide synthase [iNOS]) in response to low and 
high doses of TLR agonists but is required for Tnf and Il6 mainly under mild stimulatory 
conditions, indicating that NFAT5 could regulate specific gene patterns depending on patho-
gen burden intensity. NFAT5 exhibited two modes of association with target genes, as it was 
constitutively bound to Tnf and other genes regardless of TLR stimulation, whereas its re-
cruitment to Nos2 or Il6 required TLR activation. Further analysis revealed that TLR-induced 
recruitment of NFAT5 to Nos2 was dependent on inhibitor of B kinase (IKK)  activity and 
de novo protein synthesis, and was sensitive to histone deacetylases. In vivo, NFAT5 was 
necessary for effective immunity against Leishmania major, a parasite whose clearance re-
quires TLRs and iNOS expression in macrophages. These findings identify NFAT5 as a novel 
regulator of mammalian anti-pathogen responses.
© 2012 Buxadé et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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molecular patterns by different types of receptors. NF-B pro-
teins have a broad impact in the induction of gene expression in 
the response to pathogens because they are positioned down-
stream of TLRs, RIG-I–like receptors, and certain members of 
the NOD-like receptors and C-type lectin receptors families 
(Meylan et al., 2006; Kawai and Akira, 2007; Geijtenbeek and 
Gringhuis, 2009). In contrast, and also in the context of innate 
responses, NFATc proteins are not activated by TLRs but re-
spond to the calcium mobilization-coupled receptors Dectin 1 
and CD14 (Goodridge et al., 2007; Zanoni et al., 2009; 
Greenblatt et al., 2010). NFAT5 is a central regulator of gene 
expression in the adaptation to extracellular hypertonicity 
(Aramburu et al., 2006; Jeon et al., 2006), a function which is 
controlled by the p38 MAP kinase (Ko et al., 2002; Morancho 
et al., 2008). In contrast to NF-B and NFATc proteins, an 
immunological role for NFAT5 has remained elusive beyond 
its osmoregulatory function in leukocytes (Go et al., 2004; 
Morancho et al., 2008; Drews-Elger et al., 2009; Kino et al., 
2009; Machnik et al., 2009; Berga-Bolaños et al., 2010). 
However, NFAT5 can induce the expression of several pro-
inflammatory cytokines, growth factors, and surface receptors in 
lymphocytes and macrophages exposed to hyperosmotic stress 
(López-Rodríguez et al., 2001; Kino et al., 2009; Machnik et al., 
2009; Berga-Bolaños et al., 2010; Roth et al., 2010). The ability 
of NFAT5 to induce genes with immunomodulatory activity 
and not restricted to osmoadaptation led us to consider that, 
similarly to other Rel-like transcription factors, it might play a 
role in specific immune receptor-mediated responses.
We report that NFAT5 regulates TLR-induced gene ex-
pression in primary macrophages, and that this capacity is in-
dependent of its osmoregulatory function. NFAT5-regulated 
genes encode, among others, for cytokines and chemokines, 
extracellular matrix or protease-related proteins, regulators 
of nitric oxide production, proteins that control cell cycle 
progression and proliferation, and certain repressors of in-
flammation. NFAT5 was particularly required for the induc-
tion of genes, such as Tnf and Il6, by low doses of TLR ligands, 
but essential for the expression of Nos2 (inducible nitric 
oxide synthase [iNOS]) under both low and high doses of 
stimulus, suggesting that NFAT5 enables macrophages to 
modulate specific gene expression profiles in response to dif-
ferent stimulation thresholds. Whereas NFAT5 was expressed 
in unstimulated macrophages, it was further induced in an 
NF-B–dependent manner upon TLR stimulation, indicat-
ing that although basal levels of NFAT5 could suffice to in-
duce certain target genes, its long-term accumulation might 
contribute to sustain the prolonged expression of others. We 
found that NFAT5 exhibited two modes of association with 
target genes, as it was constitutively bound to Tnf and other 
genes regardless of TLR stimulation, whereas its recruitment 
to Nos2 or Il6 required TLR activation. Further analysis re-
vealed that the recruitment of NFAT5 to Nos2 was depen-
dent on IKK activity and de novo protein synthesis, and 
was sensitive to histone deacetylases (HDACs). These results 
indicated that NFAT5 is poised to react as a primary response 
factor for a subset of genes, but subordinated to secondary 
various strategies. A central component in control of specific-
ity is the mobilization of combinations of transcriptional reg-
ulators that are either constitutively functional or become 
expressed and/or activated upon TLR stimulation (Medzhitov 
and Horng, 2009). For instance, NF-B factors respond to all 
TLRs, but they participate in different aspects of these re-
sponses by cooperating with other transcriptional regulators, 
such as IRF3 (Wietek et al., 2003) and E2F1 (Lim et al., 2007), 
or by controlling their expression, as described for C/EBP 
(Litvak et al., 2009) and JMJD3 (De Santa et al., 2007). An-
other component accounting for TLR-induced specific gene 
expression in response to pathogens is the dynamic remodeling 
of chromatin architecture, and the recruitment of diverse co-
activator and co-repressor complexes with histone-modifying 
activity that occurs at the regulatory regions of certain genes 
(Weinmann et al., 1999; Ramirez-Carrozzi et al., 2006; 
Hargreaves et al., 2009; Ramirez-Carrozzi et al., 2009; Glass 
and Saijo, 2010). According to their transcriptional require-
ments, TLR-induced genes were recently classified in three 
main categories (Saccani et al., 2001; Ramirez-Carrozzi et al., 
2006; Hargreaves et al., 2009; Ramirez-Carrozzi et al., 2009). 
Early primary response genes, such as Tnf, Ptgs2, and Nfkbia, 
usually contain CpG island promoters, are expressed rapidly 
and independently of SWI/SNF-induced nucleosome remod-
eling or de novo protein synthesis, and are constitutively 
assembled into a chromatin structure similar to that found in 
active genes. Late primary response genes, such as Ccl5 and 
Ccl2, are also induced independently of de novo protein ex-
pression but require chromatin remodeling. Finally, induction 
of secondary response genes, such as Nos2, Il12b, and Il6, de-
pends on de novo protein synthesis and often requires SWI/
SNF-dependent nucleosome remodeling.
Although these studies have revealed general mechanistic 
principles underlying gene expression downstream of TLRs, 
and substantial knowledge on the transcriptional network act-
ing in TLR responses has been gathered in recent years, our 
current map of the identity and specific functions of the tran-
scriptional regulators involved is still incomplete. Increased 
knowledge on immune defense mechanisms that control gene 
expression during the activation of TLRs is necessary to under-
stand how host and parasite factors might predispose indi-
viduals to develop the disease or control the infection, and may 
also provide new opportunities for therapeutic intervention.
The transcription factor NFAT5 belongs to the family 
of Rel-like domain-containing factors, which comprises the 
NF-Bs and the calcineurin-dependent NFATc proteins 
(López-Rodríguez et al., 1999b, 2001; Miyakawa et al., 1999; 
Aramburu et al., 2006). NFAT5 uses a dimerization mechanism 
conserved in NF-B proteins (López-Rodríguez et al., 1999a, 
2001; Stroud et al., 2002) and, although its function is not 
dependent on the calcium-activated phosphatase calcineurin, 
NFAT5 recognizes DNA elements whose sequence coincides 
with that of sites bound by NFATc proteins (Rao et al., 1997; 
López-Rodríguez et al., 1999b; Stroud et al., 2002). NF-B 
and NFATc proteins are involved in innate immune responses 
activated upon recognition of specific pathogen-associated 
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RESULTS
NFAT5 regulates gene expression  
in macrophages in response to TLRs
Rel-like transcription factors play 
essential roles in the innate defense 
against pathogens. Because NFAT5 
is expressed in leukocytes and regulates the expression of 
diverse immunomodulatory proteins in response to osmotic 
stress, we asked whether it could participate in the transcrip-
tional response induced by specific pathogen receptors. We 
began by analyzing whether lack of NFAT5 in macrophages 
affected the TLR-mediated induction of diverse primary and 
secondary response proinflammatory and antimicrobial genes: 
response mechanisms, possibly dependent on changes in chro-
matin accessibility, for the induction of others. The relevance 
of NFAT5 in the response to pathogens in vivo was re-
vealed by the remarkable susceptibility of NFAT5-deficient 
mice to Leishmania major infection, a parasite whose clearance 
by the host requires different TLRs and iNOS expression 
in macrophages.
Figure 1. Induction of TLR-responsive 
genes in NFAT5-deficient macrophages. 
(A) mRNA expression for the indicated genes 
was measured by RT-qPCR in samples from 
Nfat5+/+ and Nfat5/ BMDMs left untreated 
() or stimulated with 0.1 ng/ml LPS for  
1–24 h. Graphs show the relative induction 
after normalization to L32 mRNA and repre-
sent the mean ± SEM of three independent 
experiments, with statistical significance 
(Student’s t test) indicated as *, P < 0.06;  
**, P < 0.01. (B) Induction of Nos2 and Il6 
mRNA was analyzed as in A, in cells stimu-
lated with 0.3 or 1 ng/ml LPS for 6 h. mRNA 
levels after normalization to L32 mRNA are 
shown relative to 1 ng/ml LPS–stimulated 
cells, which was given an arbitrary value of 
100. Values represent the mean ± SEM of 
three independent experiments. *, P < 0.05;  
**, P < 0.01. (C) Western blot for iNOS in 
Nfat5+/+ and Nfat5/ BMDMs left untreated 
() or stimulated with 10 µg/ml poly I:C (pIC) or 
10 ng/ml LPS for 2–24 h. Pyruvate kinase 
(PyrK) is shown as loading control. One repre-
sentative experiment is shown out of three 
independently performed. (D) IL-6 (top) and 
TNF (bottom) were measured by ELISA in  
cell-free supernatants from Nfat5+/+ and 
Nfat5/ BMDM cultures stimulated as indi-
cated. Values are shown relative to the cyto-
kine production in Nfat5+/+ BMDMs after 8 h 
of stimulation with 10 ng/ml LPS, represented 
as 100%. The mean ± SEM of three indepen-
dent experiments is shown (*, P < 0.06; **,  
P < 0.01). (E) Seven groups of selected NFAT5 
target genes identified by microarray analysis 
of WT and NFAT5-deficient macrophages 
treated with 0.3 ng/ml LPS for 6 h are shown 
(Table S1 contains a detailed list of genes). 
Selected genes were induced twofold or 
higher by LPS in WT cells, and their induction 
was reduced by 50% or more in NFAT5- 
deficient cells. Microarray data correspond to 
separately hybridized samples obtained from 
four independent cultures of untreated or 
LPS-stimulated Nfat5+/+ or Nfat5/ BMDMs.
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The experiments mentioned in the previous paragraph in-
dicated that NFAT5 was required for the expression of a group 
of TLR-induced genes. To get a broader view of NFAT5-
regulated genes, we performed RNA microarray analysis of 
BMDMs stimulated with LPS during 6 h, which showed that 
from a total of 755 genes induced more than twofold by LPS, 
at least 83 were regulated by NFAT5 (Fig. 1 E; and Table S1). 
Of these, 24 were induced between 4-fold and >100-fold in 
WT macrophages, and their expression was reduced by >65% 
in NFAT5-deficient cells (Table S1). These genes encoded, 
among others, for diverse proteins such as cytokines and che-
mokines, extracellular matrix or protease-related proteins, 
regulators of nitric oxide production, regulators of cell cycle 
progression and proliferation, and certain repressors of inflam-
mation (Fig. 1 E), which indicates that NFAT5 might be rele-
vant in various aspects of the response to pathogens.
Analysis of Nfat5/ BMDMs did not reveal defects in 
their maturation and capacity to activate main signaling path-
ways downstream of TLRs, including IRF3 dimerization, IB 
degradation, and phosphorylation of JNK, ERK, or p38 MAP 
kinases (Fig. S2, A–C), indicating that the specific gene ex-
pression defects observed in NFAT5-deficient BMDMs were 
not the result of a general impairment of TLR signaling. As 
NFAT5 can be activated by hypertonic stress in macrophages 
(Morancho et al., 2008; Machnik et al., 2009), we confirmed 
that culture media remained isotonic during their maturation 
from BM cells and after LPS stimulation, and that BMDMs 
Nos2, Il6, Ptgs2, Tnf, Il12b, and Ccl5, which encode for 
iNOS, IL-6, COX2, TNF, IL-12, and RANTES, respec-
tively. Our results showed that mouse BM-derived macro-
phages (BMDMs) lacking NFAT5 (Fig. S1 A) were severely 
impaired in their expression of Nos2, Il6, and Ptgs2 mRNAs 
in response to LPS (Fig. 1 A). Induction of Tnf and Il12b was 
less affected, and the induction of Ccl5 mRNA was delayed 
(Fig. 1 A). Similarly, the expression of Nos2 and Il6 in response 
to polyinosinic:polycytidylic acid (poly I:C) was substantially 
reduced in NFAT5-deficient macrophages (Fig. S1 B). There-
fore, NFAT5 regulated the expression of genes with fast in-
duction kinetics, such as Tnf, as well as genes with a slower 
and more gradual induction (Nos2 and Il6). In these experi-
ments, we used low concentrations of TLR agonists to avoid 
the activation of TLR-independent pathways (Liu et al., 2001; 
Gitlin et al., 2006). In this regard, defects in Il6 expression 
observed in Nfat5/ BMDMs were more evident at 0.3 ng/ml 
LPS than at 1 ng/ml of LPS, whereas Nos2 induction was 
substantially impaired in response to either dose (Fig. 1 B). 
Consistent with the mRNA data, TLR-activated production 
of iNOS, IL-6, and TNF proteins was decreased in Nfat5/ 
macrophages, and defects in IL-6 and TNF induction were 
more pronounced at low doses of LPS (Fig. 1, C and D). 
Impaired iNOS expression was also observed when NFAT5-
deficient BMDMs were stimulated with LPS plus IFN- 
(Fig. S1 C), which synergize to induce iNOS transcription (Xie 
et al., 1993).
Figure 2. Association of NFAT5 with regulatory regions of TLR-responsive genes. (A) Association of NFAT5 with the promoters of Nos2, Il6, and 
Ptgs2, and the enhancer region of Il12b. Formaldehyde–cross-linked chromatin from Nfat5+/+ or Nfat5/ BMDMs left untreated () or stimulated with  
1 ng/ml LPS for 2 h (or 1 h for Ptgs2) was immunoprecipitated with preimmune rabbit serum (pi) or a mixture of two rabbit polyclonal antibodies specific 
for NFAT5 (N5). Immunoprecipitated chromatin was analyzed by RT-qPCR and normalized to its respective total chromatin (input). Graphics represent the 
relative enrichment in chromatin immunoprecipitated by the NFAT5-specific antibodies compared with the input signal. A negative control showing the lack 
of binding of NFAT5 to exon 14 of the Nfat5 gene, which contains no NFAT5 binding sites, is shown. Values shown are the mean ± SEM from at least three 
independent experiments (*, P < 0.05; **, P < 0.01). (B) Binding of NFAT5 to the promoters of Tnf, Il1a, Traf1, Ccl2, and Ccl5 was analyzed as described in A.
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also required TLR stimulation (Fig. 2 A). In contrast, NFAT5 
was constitutively bound to the Tnf gene promoter regardless 
of TLR stimulation (Fig. 2 B and Fig. S4 B), possibly reflecting 
that Tnf is an early primary response gene that in resting condi-
tions is already associated with certain transcription factors and 
chromatin remodeling complexes (Ramirez-Carrozzi et al., 
2006; Hargreaves et al., 2009). This pattern of constitutive 
NFAT5 binding was also observed in other primary response 
target genes (Il1a, Traf1, and Ccl2; Fig. 2 B), but not in the pri-
mary response gene Ccl5, to which NFAT5 was recruited in 
a TLR-dependent manner (Fig. 2 B). Binding of NFAT5 to 
the proximal promoter of target genes such as Csf2, Mmp13, 
or Lcn2 was not detected, indicating that it might regulate other 
regions or contribute indirectly to their expression. As specific-
ity controls for the ChIP assay, preimmune rabbit serum did 
not immunoprecipitate any of those regulatory regions in 
WT BMDMs, and neither did the NFAT5-specific antibodies 
in Nfat5/ macrophages (Fig. 2, A and B; and Fig. S4 B). In 
addition, NFAT5 did not associate with a control genomic 
region within exon 14 of the Nfat5 gene, devoid of NFAT5 
expressed osmoresponsive genes only when exposed to hy-
pertonicity and not in response to TLRs (Fig. S3, A–C and 
Table S1). Therefore, NFAT5 was required for the expres-
sion of multiple TLR-responsive genes in macrophages in a 
hypertonicity-independent manner.
Constitutive and TLR-induced association  
of NFAT5 with target genes
Several NFAT5-regulated genes, which included primary 
and secondary TLR-response genes (Ramirez-Carrozzi et al., 
2009), contained clear consensus NFAT5 binding sites in their 
regulatory regions (5-(T/C/A)GGAAA-3; López-Rodríguez 
et al., 1999b; Fig. S4 A). Chromatin immunoprecipitation 
(ChIP) experiments showed that NFAT5 was recruited to the 
Nos2 promoter after stimulation of BMDMs with LPS or poly 
I:C (Fig. 2 A; and Fig. S4 B). Similarly, NFAT5 was recruited 
to the regulatory regions of other secondary response genes 
such as Il6 or Il12b in a TLR-dependent manner (Fig. 2 A; and 
Fig. S4 B). Binding of NFAT5 to Ptgs2, a gene with a biphasic 
primary and secondary response behavior (Caivano et al., 2001), 
Figure 3. NFAT5-dependent activation of the 
Nos2 promoter and iNOS induction. Activity of the 
hypertonicity-responsive ORE-Luc reporter (A) and the 
LPS-responsive mouse Nos2 promoter (iNOS-Luc; B) in 
RAW 264.7 cells cotransfected with a short hairpin 
RNA (shRNA) vector specific for GFP or two indepen-
dent NFAT5-specific shRNA vectors (N5-1 and N5-2), 
together with the control reporter plasmid TK-Renilla. 
Luciferase was measured 20 h after hypertonicity 
treatment (500 mOsm/kg) or LPS stimulation (25 µg/ml), 
normalized to TK-Renilla, and represented as percent-
age of reporter activity with respect to cells trans-
fected with shGFP and stimulated (100%). Graphs 
show the mean ± SEM of four independent experi-
ments. Bottom panels show the Western blot for 
NFAT5 done in parallel to the reporter assays. Pyruvate 
kinase (PyrK) is shown as loading control. Results are 
representative of three independent experiments.  
(C) Activity of WT mouse Nos2 promoter construct 
(WT) or an NFAT5-binding site mutant (NFAT5 mut) in 
RAW 264.7 cells after 20 h of LPS stimulation. Lucifer-
ase activity normalized to TK-Renilla is represented as 
fold induction relative to the reporter activity in un-
stimulated cells. Graphs show the mean ± SEM of 
three independent experiments. (D) Activation of the 
Nos2 promoter in response to different TLR agonists 
was measured in RAW 264.7 cells cotransfected with 
the iNOS-Luc and TK-Renilla reporters plus either 
shGFP or shN5-1 vectors. Transfected cells were stimu-
lated for 20 h with 1 µg/ml Pam3CSK4 (P3C), 300 µg/ml 
zymosan A (Zym), 100 µg/ml poly I:C (pIC), 25 µg/ml 
LPS, 1 mM loxoribine (Lox), or 1 µM CpG oligodeoxy-
nucleotide (CpG). Luciferase activity normalized to  
TK-Renilla is represented as fold induction over the 
reporter activity in unstimulated cells (). Graphics 
show the mean ± SEM of three independent experiments. (E) RAW 264.7 cells transfected with either shGFP or shN5-1 vectors were left untreated or stimu-
lated with different TLR ligands as in D. Expression of NFAT5, iNOS, and pyruvate kinase (normalization control) was detected by Western blotting. The experi-
ment shown is representative of three independently performed. (F) Nitric oxide production upon 24 h of stimulation with 100 µg/ml pIC or 25 µg/ml LPS in 
RAW 264.7 cells transfected with either shGFP or shN5-1 vectors. Graphics show the mean ± SEM of three independent experiments.
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upon inactivation of IKK with two independent phar-
macological inhibitors, BAY 11–7082 and BMS-345541, 
to an extent comparable to that of blocking transcription 
(Fig. 4 F). In addition, pharmacological and genetic inacti-
vation of IKK prevented the long-term accumulation of 
NFAT5 in response to TLRs, but inhibition of other TLR-
activated pathways, such as p38, ERK, JNK, PI3K, and mTOR, 
did not affect it (Fig. 4, G and H). Altogether, these data in-
dicated that de novo expression of NFAT5 after TLR activa-
tion required NF-B–dependent transcription.
Different mechanisms regulate the TLR-induced recruitment 
of NFAT5 to its target genes
Our results showed that, although NFAT5 was constitutively 
bound to target genes that are independent of TLR-induced 
chromatin remodeling, it required TLR stimulation to be re-
cruited to most targets that are expressed upon chromatin re-
modeling. In this regard, TLR-induced binding of NFAT5 
to Nos2 could be detected after 30 min of stimulation and 
neared a maximum by 2 h (Fig. 5 A). Because this rapid 
recruitment occurred before any substantial accumulation 
of newly synthesized NFAT5 (Fig. 4, B and D), it could be 
used to monitor the effect of different TLR-activated signals 
on the specific recruitment of NFAT5 to its targets. We 
observed that binding of NFAT5 to the Nos2 promoter, in-
duced by a 2-h LPS stimulation, was sensitive to inhibition 
of IKK using two chemically unrelated pharmacological 
inhibitors (Fig. 5 B). Confirmation of the dependence of 
NFAT5 recruitment to Nos2 on IKK was obtained using 
IKK-deficient BMDMs, in which the LPS-induced binding 
of NFAT5 to the Nos2 promoter was significantly reduced, 
to a similar extent as the decrease in p65 activation (Fig. 5 C 
and Fig. S5 A). In contrast, the constitutive association of 
NFAT5 with Tnf was maintained in LPS-treated IKK-
deficient macrophages (Fig. 5 C). We also observed that 
inhibition of the MAP kinases p38, ERK, and JNK did not 
prevent the TLR-induced binding of NFAT5 to Nos2 
(Fig. 5 D). Because p38 is a major activator of NFAT5 in os-
mostress responses (Ko et al., 2002; Morancho et al., 2008), this 
result indicated that NFAT5 binding to TLR- or osmostress-
responsive genes likely involved different mechanisms.
LPS-induced expression of iNOS involves a rapid, NF-B–
dependent removal of repressor complexes associated with 
HDACs from the Nos2 promoter (Ogawa et al., 2004; Pascual 
et al., 2005; Huang et al., 2009). Moreover, although it has 
not been specifically determined for Nos2, TLR-induced 
chromatin remodeling in other secondary response genes de-
pends on de novo protein synthesis (Weinmann et al., 1999; 
Ramirez-Carrozzi et al., 2006). Therefore, we analyzed whether 
the TLR-induced recruitment of NFAT5 to genes such as 
Nos2 was also sensitive to de novo protein synthesis and HDAC 
activity. We observed that binding of NFAT5 to Nos2 and 
Il12b was decreased by blockade of protein synthesis with 
CHX in LPS-stimulated cells (Fig. 5 E). In contrast, its con-
stitutive association with the primary response genes Tnf and 
Ccl2 was not affected by CHX (Fig. 5 E), and, moreover, 
binding sites (López-Rodríguez et al., 2001; Fig. 2 A; and 
Fig. S4 B). Altogether, our data indicated that NFAT5 ex-
hibited two general patterns of association with its direct 
target genes in macrophages: it was constitutively bound to 
most primary response target genes in unstimulated macro-
phages, but its recruitment to secondary response genes required 
TLR activation.
NFAT5 regulates the TLR-induced activation  
of the Nos2 promoter
Given that iNOS induction by TLRs was severely impaired 
in NFAT5-deficient BMDMs, we analyzed the direct reg-
ulation of the Nos2 gene promoter by NFAT5 in RAW 264.7 
macrophage cells. Two independent NFAT5-specific shRNAs 
(shN5-1 and shN5-2), whose effectiveness we had previously 
validated with an osmostress-responsive, NFAT5-dependent 
reporter (Fig. 3 A), inhibited the activation of the iNOS-Luc 
reporter by LPS (Fig. 3 B). Likewise, mutation of the NFAT5 
binding site in iNOS-Luc abrogated its responsiveness to LPS 
(Fig. 3 C). Suppression of NFAT5 also impaired the acti-
vation of the iNOS reporter by agonists of different TLRs 
(Fig. 3 D) and prevented iNOS expression as well as nitric 
oxide production (Fig. 3, E and F). These findings, together 
with our previous ChIP results, showed that NFAT5 is a di-
rect regulator of iNOS transcription, and further supported 
the interpretation that defective gene expression in NFAT5-
deficient macrophages activated by TLRs was specifically a 
result of the lack of this factor.
TLR-induced NFAT5 expression is regulated  
by the IKK–NF-B pathway
Activation of TLRs induced a progressive accumulation of 
NFAT5 protein that was preceded by an increase in its 
mRNA (Fig. 4, A and B) and was dependent on transcription 
because it was blunted by the RNA synthesis inhibitors 
actinomycin d and -amanitin (Fig. 4 C). The accumulation 
of NFAT5 protein increased slowly in response to TLRs 
(Fig. 4 B), and during the first 2 h its abundance was largely 
insensitive to cycloheximide (CHX), whereas by 4 h a more 
substantial CHX-sensitive accumulation, suggestive of de novo 
synthesis, was observed (Fig. 4 D). These results suggested 
that basal levels of preexisting NFAT5 might be sufficient 
to initiate expression of genes with fast induction kinetics, 
such as Tnf, whereas its sustained accumulation at later time 
points could contribute to prolong the expression of genes 
with slower induction kinetics, like Nos2.
The oscillatory pattern of NFAT5 mRNA induction in 
TLR-stimulated macrophages was reminiscent of NF-B–
regulated genes (Hoffmann et al., 2002) and led us to examine 
whether this factor might control NFAT5 expression. Analysis 
of the Nfat5 gene revealed two clear NF-B consensus bind-
ing sites upstream of Nfat5 exon 1 that were remarkably con-
served across several mammalian species (Fig. 4 E). ChIP 
experiments showed that p65 (p65/NF-B) was readily re-
cruited to these sites upon TLR activation (Fig. 4 E). Moreover, 
TLR-induced accumulation of Nfat5 mRNA was blunted 
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Figure 4. Involvement of the IKK–NF-B pathway on the expression of NFAT5 in response to TLRs. (A) Quantification of NFAT5 mRNA upon stimula-
tion of BMDMs with 10 µg/ml pIC or 10 ng/ml LPS for the indicated times. mRNA content was measured by RT-qPCR, normalized to L32 mRNA, and is shown 
relative to unstimulated cells, which was given an arbitrary value of 1. (B) Expression of NFAT5 in BMDMs stimulated with 1 µg/ml pIC or 1 ng/ml LPS for the indi-
cated times was analyzed by Western blot. -Tubulin is shown as loading control. (C) Western blot for NFAT5 in BMDMs left untreated (), or stimulated with  
10 ng/ml LPS (20 h) after 1 h of pretreatment with actinomycin d (ActD) or -amanitin (-Ama) at the indicated concentrations. Pyruvate kinase (PyrK) is shown 
as loading control. (D) Western blot for NFAT5 in BMDMs treated with 0.5 µg/ml CHX, 1 ng/ml LPS, or both during different times (CHX was added 30 min before 
LPS). To ensure the complete extraction of NFAT5 from cells we used urea-based whole-cell lysates. IB is shown as a de novo synthesis-dependent TLR-induced 
protein. -Tubulin was used as loading control. (E) Schematic representation of the promoter region of the Nfat5 gene. Consensus binding sites for NF-B (capital 
letters) and flanking sequences are shown for human, dog, mouse, and pig genomes. CpG-rich designate a CpG island, and the small bar under the NF-B binding 
sites in the diagram shows the region amplified by the primers used in the ChIP experiments. The bottom panels show the ChIP analysis of NF-B (p65) binding to 
the Nfat5 promoter or an irrelevant region (exon 14 of the Nfat5 gene) in BMDMs left untreated () or stimulated with 10 ng/ml LPS for 2 or 4 h. A control rabbit 
IgG (Ig) was included as negative control. Immunoprecipitated chromatin was analyzed by RT-qPCR and normalized to its respective total chromatin (input). 
Graphics represent the enrichment in chromatin immunoprecipitated by the NF-B–specific antibody relative to the immunoprecipitation with the control IgG in 
unstimulated cells (which was given an arbitrary value of 1). (F) NFAT5 mRNA levels in BMDMs stimulated during 2 h with 10 µg/ml pIC or 10 ng/ml LPS without 
or with a 1-h pretreatment with 10 µM BAY 11–7082, 2 µM BMS-345541, or 0.1 µg/ml actinomycin d (ActD). (G) Western blot for NFAT5 in BMDMs left untreated 
(), or stimulated with 10 ng/ml LPS for 20 h without inhibitors or with a 1-h pretreatment with 10 µM BAY 11–7082, 2 µM BMS-345541, 10 µM SB202190,  
10 µM PD098059, 10 µM SP600125, 1 µM dexamethasone, 20 µM LY294002, or 200 nM rapamycin. DMSO and ethanol (EtOH) are vehicle controls. (H) Western blot 
for NFAT5 in WT (IKK+/+) and IKK-deficient (IKK/) BMDMs left untreated () or stimulated with 10 ng/ml LPS for 15 h. Graphics in A, E, and F correspond to 
the mean ± SEM of three independent experiments (*, P < 0.05; **, P < 0.01). Results in B, C, D, G, and H are representative of three independent experiments.
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stimulation, inhibition of HDACs sufficed to induce the as-
sociation of NFAT5 with target genes whose expression re-
quires chromatin remodeling. Although it cannot be ruled 
out that TSA could cause other effects in addition to inhibit-
ing histone deacetylation, this result lends support to the con-
cept that inhibition of HDACs, which occurs upon TLR 
activation (Glass and Saijo, 2010), could favor the recruit-
ment of NFAT5 to genes such as Nos2. Altogether, our re-
sults indicate that recruitment of NFAT5 to these genes 
might be sensitive to TLR-induced changes in chromatin 
configuration involving IKK–NF-B, de novo protein syn-
thesis, and HDAC inhibition.
In vivo response of NFAT5-deficient mice to L. major infection
We next sought to determine the impact of NFAT5 defi-
ciency on the in vivo response against L. major infection, a 
model in which pathogen clearance requires different TLRs 
NFAT5 appeared capable of enhancing the induction of Tnf 
mRNA despite blockade of protein synthesis because CHX-
treated WT macrophages induced it better than NFAT5-
deficient ones (Fig. S5 B). In the same experiments, CHX 
abrogated the induction of Nos2 mRNA (Fig. S5 B). Alto-
gether, these results indicated that preexisting, promoter-
bound NFAT5 could enhance the transcription of genes such 
as Tnf without additional protein synthesis, whereas the induc-
ible recruitment of NFAT5 to other genes, like Nos2, required 
de novo protein synthesis and IKK activity.
We then tested the effect of the HDAC inhibitor tricho-
statin A (TSA) on the chromatin-binding capacity of NFAT5. 
TSA induced the binding of NFAT5 to the Nos2 promoter 
in unstimulated macrophages nearly as efficiently as LPS stimu-
lation (Fig. 5 F). Similarly, association of NFAT5 with the Il12b 
enhancer was induced by TSA in unstimulated macrophages. 
These observations indicated that, in the absence of TLR 
Figure 5. Effect of TLR-activated signal-
ing pathways, protein synthesis, and HDAC 
inhibition on the recruitment of NFAT5 to 
target genes. (A) Time course of NFAT5 re-
cruitment to the Nos2 promoter in BMDMs 
stimulated with 10 ng/ml LPS was analyzed by 
ChIP. Chromatin in each sample was immuno-
precipitated with preimmune rabbit serum (pi) 
or NFAT5-specific antibodies (N5) and is rep-
resented as relative enrichment after normal-
ization to its respective total chromatin 
(input). The anti-NFAT5–immunoprecipitated 
chromatin in unstimulated cells was used as 
reference sample and given an arbitrary value 
of 1. (B) BMDMs left untreated () or pre-
treated (1 h) with BAY 11–7082 (5 and 10 µM) 
or BMS-345541 (2 and 6 µM) were stimulated 
with 10 ng/ml LPS for 2 h and analyzed by 
ChIP. The anti-NFAT5–immunoprecipitated 
chromatin in LPS-stimulated cells was used as 
reference sample and given an arbitrary value 
of 100%. (C) The association of NFAT5 with 
the Nos2 and Tnf promoters in IKK+/+ and 
IKK/ BMDMs after stimulation with 10 ng/ml  
LPS for 1 h was analyzed by ChIP. (D) BMDMs 
left untreated () or pretreated (1 h) with  
10 µM SB202190, 10 µM PD098059, and  
10 µM SP600125 were stimulated with 10 ng/ml 
LPS during 4 h and subjected to ChIP to ana-
lyze the recruitment of NFAT5 to the Nos2 
promoter. (E) The association of NFAT5 with 
the promoter regions of Nos2, Tnf, Ccl2, and 
the enhancer region of Il12b, was analyzed in 
WT BMDMs left untreated () or stimulated 
for 2 h with 0.1 ng/ml or 1 ng/ml LPS in the 
presence or absence of 10 µg/ml CHX. Immuno-
precipitated chromatin in each sample was 
normalized to its respective total chromatin (input). The anti-NFAT5–immunoprecipitated chromatin in cells stimulated with 1 ng/ml LPS was used as 
reference sample and given an arbitrary value of 100%. (F) As in E, but cells were left untreated or treated as indicated with TSA for 5 h, or stimulated 
with 10 ng/ml LPS for 2 h. The enrichment in chromatin immunoprecipitated by the NFAT5-specific antibodies is represented relative to the amount  
immunoprecipitated by the NFAT5 antibodies upon LPS stimulation (which was given an arbitrary value of 100). Graphics show the mean ± SEM of three  
(A, B, C, E, and F) or four (D) independent experiments (*, P < 0.05; **, P < 0.01).
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locally and no parasites were detected in the spleen of WT 
mice, a marked colonization (102 parasites/ spleen) was ob-
served in NFAT5-deficient mice (Fig. 6 E). Therefore, our 
data show that NFAT5 is a key factor in the in vivo response 
to Leishmania by contributing to iNOS expression in macro-
phages and control of L. major replication and dissemination.
DISCUSSION
Regulation of gene expression induced by TLRs must inte-
grate variables such as the type of stimulus, the signal strength, 
and even the repeated encounter with the pathogen they rec-
ognize (Foster et al., 2007; Litvak et al., 2009). Current knowl-
edge on transcriptional regulators and mechanisms involved 
in the induction of specific genes downstream TLRs is still 
incomplete. In this study, we identify NFAT5 as a key regulator 
of gene expression in macrophages in response to TLR stimu-
lation and show that it is required for efficient anti-pathogen 
responses in vivo. Remarkably, this function of NFAT5 is in-
dependent of its previously characterized role in the adaptation 
to hypertonic stress.
Until very recently, NF-B proteins were the only Rel- 
like transcription factors known to be involved in innate 
immune responses activated by receptors that recognize 
pathogens. This notion was changed by findings describing that 
and their adaptor molecule MyD88 (de Veer et al., 2003; 
Muraille et al., 2003; Kropf et al., 2004a; Tuon et al., 2008). 
Production of nitric oxide by iNOS, whose gene is a major 
target for NFAT5 in the response to TLRs, is a key mecha-
nism for the control and clearance of L. major in vivo (Bogdan 
et al., 2000; Kropf et al., 2004b) and, in addition, Nfat5/ 
mice and their WT littermates have a 129/sv background, a 
resistant strain in which L. major causes a localized infection 
(Swihart et al., 1995; Lipoldová and Demant, 2006). Mice 
were infected with a low dose of parasites in the ear or a high 
dose in the footpad. As expected (Diefenbach et al., 1998), 
macrophages (F4/80+) of WT mice up-regulated iNOS ex-
pression at the inoculation site 24 h after infection (Fig. 6 A) 
which, after a peak at 48 h, decreased to baseline by 72 h 
with either high or low doses of infection (Fig. 6 B). In 
contrast, iNOS expression in macrophages from NFAT5-
deficient mice was only mildly up-regulated at 48 h after 
infection (Fig. 6, A and B). Impaired iNOS expression in 
skin macrophages of NFAT5-deficient mice correlated well 
with the 5–20-fold higher parasite burden observed in those 
mice compared with WT ones 72 h after a high-dose infection 
(Fig. 6 C), and a 20-fold higher parasite burden in the ear and 
retromaxillar draining lymph nodes 3 wk after a low-dose in-
fection (Fig. 6 D). Notably, although infection was controlled 
Figure 6. In vivo response of NFAT5-deficient mice to L. major infection. (A) Intracellular iNOS expression in macrophages from the footpads of 
WT (left) and NFAT5-deficient (right) mice after infection with L. major. Mice were injected with PBS (filled histogram) or inoculated with 5 × 105 L. major 
parasites (thick line histogram) in the footpad. After 24 h, cell suspensions from the skin were stained with antibodies to F4/80 and iNOS, and analyzed by 
flow cytometry. The dotted line represents the staining with an isotype control antibody. A representative experiment of a total of eight performed (each 
footpad from four mice of each group, WT and KO) is shown. (B) As in A, but the median intensity of fluorescence (MFI) of intracellular iNOS staining in 
F4/80+ macrophages is represented at the indicated time points. The mean ± SEM of four mice per group is shown. For the 0-h time point, the MFI values 
for intracellular iNOS correspond to PBS injection. (C and D) Parasite load was determined in the locally infected skin and draining lymph node (dLN), 72 h 
after high-dose infection in the footpad (C) or 3 wk after low-dose infection in the ear (D). The parasite burden for each individual mouse is depicted in 
logarithmic scale (Log10). The horizontal bars represent the mean values for each group: (C) footpads (Nfat5+/+ n = 12 and Nfat5/ n = 16) and popliteal 
dLN (Nfat5+/+ n = 6 and Nfat5/ n = 8); (D) ears (Nfat5+/+ n = 30 and Nfat5/ n = 20) and retromaxillar dLN (Nfat5+/+ n = 15 and Nfat5/ n = 10).  
(E) Analysis of parasite dissemination after L. major infection. The graph represents the quantification of the parasite load in the spleen of Nfat5+/+ (n = 15) 
and Nfat5/ (n = 10) infected mice 3 wk after a low-dose inoculation. The horizontal bars represent the mean values for each group in logarithmic scale 
(Log10). All but one WT animal had parasite burdens below the detection limit of the technique (2.2 parasites/ organ). For C, D, and E: three series of inde-
pendent infections were performed. *, P = 0.01; ***, P < 0.0001, Student’s t test of WT compared with NFAT5-deficient mice.
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regulators and chromatin remodeling complexes in basal 
conditions, which likely facilitates their rapid induction upon 
TLR activation (Ramirez-Carrozzi et al., 2006; Hargreaves 
et al., 2009). This finding also recalls earlier works describing 
a constitutive nuclear pool of NFAT5 in different cell types 
(López-Rodríguez et al., 1999b, 2001) and raises the question 
of whether this factor might mark a wider set of genes to 
facilitate their response to diverse stimuli.
The dependence of NFAT5 on de novo protein synthesis 
for binding to genes such as Nos2 or Il12b did not seem to 
be a result of new synthesis of NFAT5 itself because its abun-
dance was minimally affected by CHX during the stimulation 
time used in these experiments (2 h), and it strongly suggests 
that NFAT5 could require a TLR-induced regulator to be re-
cruited to this group of genes. Binding of NFAT5 to these 
genes could also be induced without TLR stimulation by 
inhibiting HDACs with TSA. Although it cannot be ruled 
out that TSA could act through other mechanisms in addition 
to inhibiting histone deacetylation, this result suggests that 
TLR-induced recruitment of NFAT5 to target genes might 
be primarily controlled by chromatin accessibility. Further 
analysis showed that recruitment of NFAT5 to Nos2 required 
IKK, which could potentially act through diverse mechanisms, 
such as causing posttranslational modifications in NFAT5 
or regulatory factors, or inducing, via NF-B, the de novo ex-
pression of a chromatin modifier or a potential NFAT5 part-
ner. Although it remains to be determined whether the need 
of de novo protein synthesis, sensitivity to HDACs, and regu-
lation by IKK are part of a common mechanism, our com-
bined results suggest that access of NFAT5 to Nos2 and other 
genes might be controlled by TLR-activated and/or de novo 
synthesized factors capable of influencing chromatin configu-
ration. Such interpretation is consistent with works showing 
that TLR-induced chromatin remodeling of genes such as 
Il12b and Il6 requires de novo protein synthesis (Weinmann 
et al., 1999; Ramirez-Carrozzi et al., 2006). In addition, TLRs 
induce the expression of transcriptional regulators and proteins 
with chromatin remodeling activity, such as C/EBP, IB, 
JMJD3, IB, and IKK (Yamamoto et al., 2004; De Santa 
et al., 2007; Kayama et al., 2008; Huang et al., 2009; Litvak 
et al., 2009; Rao et al., 2010), and TLR-activated NF-B can 
de-repress genes such as Nos2 by clearing HDAC complexes 
(Huang et al., 2009; Glass and Saijo, 2010). The finding that 
recruitment of NFAT5 to some of its targets depends on pro-
tein synthesis also illustrates one mechanism by which de novo 
protein expression could control the induction of certain 
secondary response genes.
We found that the NF-B pathway regulates NFAT5 
accumulation downstream of TLRs. As shown recently, the 
NF-B pathway can adjust the expression of genes in response 
to persistent TLR signals by controlling the induction of 
C/EBP (Litvak et al., 2009). The regulation of NFAT5 
expression by NF-B, and its being particularly required for 
the induction of certain genes, such as Il6, at low doses of stim-
uli, suggest that NFAT5 could be a relevant component in 
specific NF-B–regulated coherent feed-forward loops of 
calcineurin-regulated NFATc proteins are activated in innate 
immune cells by the LPS receptor CD14 or the C-type lectin 
receptor Dectin-1, although not by TLRs (Goodridge et al., 
2007; Zanoni et al., 2009; Greenblatt et al., 2010). Our work 
now reveals that NFAT5, a distinct Rel-like protein with 
functional and structural features shared with NF-B and 
NFATc proteins, is also a regulator of TLR-induced gene 
expression. It remains to be addressed whether, like other Rel-
domain transcription factors, NFAT5 is involved in responses 
mediated by other pattern-recognition receptors, such as 
RIG-like receptors, C-type lectin receptors, and NOD-like 
receptors (Geijtenbeek and Gringhuis, 2009; Takeuchi and 
Akira, 2010).
NFAT5 controlled the expression of a set of genes involved 
in different aspects of the response to pathogens. Some of the 
NFAT5-regulated genes identified here (Tnf and Ccl2) can 
be also induced by NFAT5 in macrophages under osmotic 
stress (Roth et al., 2010). However, we found that other genes 
previously shown to be inducible by osmotic stress in an 
NFAT5-dependent manner, such as Vegfc and Nfkbia (Machnik 
et al., 2009; Roth et al., 2010), did not require NFAT5 to be 
expressed in response to LPS. In addition, TLR stimulation 
did not induce any of the NFAT5-target genes, such as 
Hspa1b, Akr1b3, and Slc5a, which are characteristically ex-
pressed upon osmostress in numerous cell types (Aramburu 
et al., 2006). Although microarray studies of osmorespon-
sive genes in macrophages have not been reported, it seems 
likely that NFAT5 might be able to regulate some genes 
under both types of stimuli: TLR and osmotic stress. None-
theless, the overlapping would be limited, as osmotic stress and 
TLRs use different signaling pathways and contexts of 
transcriptional regulators.
The requirement of NFAT5 for the expression of TLR-
regulated genes such as Tnf and Il6, particularly under low 
stimulus doses, suggests a role for this factor in coupling the 
strength of signal input to the specificity of gene expression. 
This property of NFAT5 recalls the requirement for C/EBP 
in Il6 induction during persistent, but not transient, TLR4 
responses (Litvak et al., 2009). Therefore, NFAT5 and C/EBP 
represent examples of transcription factors capable of selec-
tively regulating gene expression in the low and high ranges 
of TLR stimulation. In this regard, NFAT5 could be well 
suited for fine tuning the expression of its target genes by 
lowering their inducibility threshold.
The ability of NFAT5 to regulate genes with different 
transcriptional requirements suggests that it could participate 
in diverse architectures of transcriptional complexes. In this 
regard, NFAT5 showed two distinct patterns of association 
with its target genes: it required TLR activation and de novo 
protein synthesis to bind a subset of them but was constitu-
tively bound to others regardless of stimulation. Genes to 
which NFAT5 was bound in basal conditions were primary 
response, whereas genes to which its binding required TLR 
stimulation were chromatin remodeling dependent. These 
observations fit the notion that numerous primary response 
genes, such as Tnf, are already bound by certain transcription 
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medium plus 20% FCS. The number of viable parasites was determined from 
the highest dilution at which promastigotes could be grown after up to 7 d of 
incubation at 26°C. In the ear, local draining lymph nodes of infected ears 
(retromaxillary) and footpad (popliteal), and spleen, the parasite load is ex-
pressed as the number of parasites in the whole organ. In the footpad, the 
parasite load is expressed as the number of parasites per microgram of tissue. 
iNOS protein expression was assessed by flow cytometry after intracellular 
staining, as previously described (Angulo et al., 2000). At the indicated times 
after L. major infection, footpad sections and ears were recovered from the in-
fected mice as previously described (Iborra et al., 2005). In brief, the ventral 
and dorsal sheets of the infected ears were separated. The footpad sections and 
ear sheets were placed in DME containing 50 µg/ml Liberase CI enzyme 
blend (Roche). After 2 h of incubation at 37°C, the tissues were cut into 
small pieces, homogenized, and filtered using a cell strainer (70-µm pore size). 
Cells were first incubated with an antibody to the Fc receptor (BD) and then 
stained for surface F4/80 (APC-conjugated antibody to mouse F4/80; eBio-
science), fixed, and incubated with a monoclonal antibody to iNOS during 
permeabilization (Dako). FITC-conjugated iNOS antibody (BD), or the ap-
propriate FITC-conjugated mouse IgG2a isotype control, was used. Events 
were acquired using a FACSCanto flow cytometer (BD) and data were ana-
lyzed using FACSDiva (BD) and FlowJo (Tree Star) software.
Reagents. Pam3CSK4 was from InvivoGen; zymosan A, polyI:C, LPS 
from E. coli 055:B5, and loxoribine were from Sigma-Aldrich; CpG DNA 
was from Hycult Biotechnology; and recombinant mouse IFN- was pur-
chased from ImmunoTools. Formaldehyde, sodium chloride, Trizma base, 
glycine, EDTA, iodoacetamide, sodium pyrophosphate (NaPPi), sodium or-
thovanadate, -glycerophosphate, PMSF, leupeptin, pepstatin A, aprotinin, 
SDS, Tween-20, glycine, methanol, Triton X-100 (TX-100), Nonidet P-40, 
sodium deoxycholate, actinomycin d, dexamethasone, TSA, and CHX were 
from Sigma-Aldrich. Sodium fluoride (NaF) was from Merck. -Amanitin, 
SB202190, PD98059, SP600125, BAY 11–7082, BMS-345541, LY294002, 
and rapamycin were from EMD.
Isolation of cells and cell culture. Mouse RAW 264.7 macrophage cells 
(American Type Culture Collection) were grown in RPMI 1640 (Invitrogen), 
supplemented with 10% heat-inactivated fetal bovine serum (Hyclone or In-
vitrogen), 2 mM glutamine (Invitrogen), 50 µM -mercaptoethanol (Sigma-
Aldrich), and 1 mM sodium pyruvate (Invitrogen; complete RPMI medium). 
To obtain BMDMs, 6–8-wk-old mice were sacrificed and the femoral and 
tibial marrow was flushed from the bones with DME supplemented with 2 mM 
glutamine, 50 µM -mercaptoethanol, and 1 mM sodium pyruvate plus 
penicillin/streptomycin (Invitrogen; incomplete medium). Cells were then 
resuspended in complete DME media (incomplete supplemented with 10% 
heat inactivated fetal bovine serum) with 25% (vol/vol) L929-conditioned 
medium (as the source of macrophage-colony stimulating factor) and incu-
bated for 7 d in polystyrene dishes. Differentiated macrophages were har-
vested with PBS plus 1 mM EDTA by gentle pipetting, washed with PBS, 
and plated in tissue culture plates for Western blot, mRNA, and ELISA 
analysis (2 × 106 cells/3 ml/well). Where indicated, the culture medium was 
made hypertonic (500 mOsm/kg) by the addition of 90 mM NaCl from a 
sterile 4 M stock solution. Osmolality was measured with a vapor pressure 
osmometer (VAPRO 5520; Wescor).
RAW 264.7 transfection, luciferase assay, and quantification of ni-
trite levels. RAW 264.7 cells were transfected by electroporation. In brief, 
10 × 106 cells in 0.4 ml of ice-cold complete RPMI medium with 20 µg of 
DNA per cuvette (4-mm gap width; Isogen) were electroporated in a Gene 
Pulser II (Bio-Rad Laboratories) at 320 V and 975 µF (time constant ranging 
from 22 to 30 ms). For reporter gene experiments, cells were lysed in passive 
lysis buffer (PLB; Promega) at 25 × 106 cells/ml and the activity of Firefly 
and Renilla luciferases was measured with the Dual-luciferase reporter sys-
tem (Promega) with a Berthold FB12 luminometer (Berthold). Firefly lucif-
erase units were normalized with respect to the activity of Renilla luciferase. 
The concentration of nitrite produced by RAW 264.7 cells was determined 
using the Griess assay (Invitrogen) according to manufacturer’s indications. 
transcriptional circuits involved in sensing low input signals 
from TLRs (Shoval and Alon, 2010). In addition, the progres-
sive NF-B–dependent increase of NFAT5 in TLR-stimulated 
macrophages could be particularly important to sustain the 
expression of genes with slow induction kinetics, such as Nos2 
or Il6.
Finally, our analysis revealed NFAT5 as a key host factor 
required for controlling infection by L. major, whose clearance 
strongly depends on TLRs (Tuon et al., 2008) and iNOS pro-
duction by macrophages (Bogdan et al., 2000; Kropf et al., 
2004b). NFAT5-null mice exhibited defective control of the 
parasite burden at the point of infection and presented colo-
nization of the spleen, resembling the phenotype described for 
iNOS-deficient mice (Diefenbach et al., 1998), and, indeed, 
also displayed reduced iNOS expression in local macrophages 
during L. major infection. The dissemination of the parasite to 
organs such as the spleen in NFAT5-deficient mice was indic-
ative of visceral leishmaniasis, the most pernicious manifesta-
tion of chronic Leishmania infection in humans (Engwerda and 
Kaye, 2000). These findings underscore the biological rele-
vance of NFAT5 in the response to pathogens, as they show 
that its deficiency can cause normally resistant 129/sv mice to 
become highly susceptible to L. major.
MATERIALS AND METHODS
Mice. Mice heterozygous for Nfat5 were described previously (López-
Rodríguez et al., 2004). Because NFAT5-null mice in a mixed 129/ 
sv-C57BL/6 background had a severe mortality rate from late embryonic 
development to early perinatal stages (Go et al., 2004; López-Rodríguez 
et al., 2004), we bred them for >10 generations to a pure 129/sv background 
and observed that the rate of survival of NFAT5-null mice (Nfat5/) increased, 
with >30% of the expected Mendelian ratio of Nfat5/ mice reaching adult-
hood. Nfat5+/ mice were maintained in an isogenic 129/sv background and 
were crossed to obtain Nfat5/ mice and control Nfat5+/+ littermates. Con-
ditional mice that lack IKK in macrophages, Ikbkbfl/fl,Lys-M-Cre, were generated 
crossing Lys-M-Cre mice with Ikbkbfl/fl mice. Lys-M-Cre mice (Clausen et al., 
1999) were obtained from The Jackson Laboratory and the Ikbkbfl/fl mice were 
provided by M. Schmidt-Supprian (Pasparakis et al., 2002). Ikbkbfl/fl,Lys-M-Cre 
(IKK/) and littermate Ikbkbwt/wt,Lys-M-Cre or Ikbkbfl/fl control mice 
(IKK+/+) were maintained on a pure C57BL/6 background. All mice were 
analyzed between 6 and 8 wk of age. Mice were bred and maintained in spe-
cific pathogen-free conditions, and animal handling was performed according 
to institutional guidelines approved by the ethical committee (PRBB/
UPF Animal Care and Use Committee).
In vivo infection with Leishmania. For parasite challenge, L. major para-
sites clone V1 (MHOM/IL/80/Friedlin; provided by M. Soto, Universidad 
Autónoma de Madrid, Madrid, Spain) were kept in a virulent state by passage 
in BALB/c mice. The L. major amastigotes were obtained from popliteal 
lymph nodes of infected BALB/c mice. For transformation from amastigotes 
to promastigotes, parasites were cultured at 26°C in Schneider’s medium 
(Invitrogen) supplemented with 20% fetal calf serum. Infective-stage metacyclic 
promastigotes were isolated from stationary cultures by negative selection 
using peanut agglutinin (Vector Laboratories; Sacks et al., 1985). Nfat5/ or 
littermate control male mice were infected either by intradermal inoculation 
of 104 metacyclic promastigotes of L. major into the dermis of both ears of 
each mouse (low dose) or by subcutaneous inoculation in both footpads with 
5 × 105 metacyclic promastigotes (high dose). Three series of independent 
infections were performed. The limiting dilution assay (Buffet et al., 1995) 
was used to determine the number of parasites. In brief, homogenized ear and 
footpad tissue, and mechanically dissociated lymph nodes and spleens, were seri-
ally diluted in a 96-well flat-bottomed microtiter plate containing Schneider’s 
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a FACScan flow cytometer and CellQuest software (BD). FITC-labeled 
antibodies to CD11b (BD) or F4/80 (AbD Serotec) were used.
Measurement of mRNA levels. Total RNA from BMDMs (2 × 106) 
was isolated using the High Pure RNA Isolation kit (Roche), quantified 
in a NanoDrop (ND-1000) spectrophotometer, and 1–2 µg of total RNA 
(50–100 ng for RNA from peritoneal macrophages) was retro-transcribed 
to cDNA using SuperScript III reverse transcription and random primers 
(Invitrogen). For real-time quantitative PCR (RT-qPCR), LightCycler 480 
SYBR Green I Master (Roche), LightCycler 480 Multiwell Plate (Roche), 
and the LightCycler 480 Real-Time PCR System (Roche) were used 
according to the instructions provided by the manufacturers. Samples were 
normalized to L32 (L32 ribosomal protein gene) mRNA levels using the 
LightCycler Software, version 1.5. Primer sequences for the PCR reactions 
are described in Table S2.
Microarray analysis. 2 × 106 BMDMs left untreated or stimulated for 6 h with 
0.3 ng/ml LPS were lysed in 300 µl RLT buffer (RNeasy system; QIAGEN) 
and total RNA was isolated using the same system. The RNA integrity was 
assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies). Label-
ing and hybridizations were performed according to protocols from Af-
fymetrix. In brief, 100–300 ng of total RNA were amplified and labeled 
using the WT Sense Target labeling system and control reagents (Affyme-
trix), and then hybridized to Mouse Gene 1.0 ST Array (Affymetrix). Wash-
ing and scanning were performed using the GeneChip System of Affymetrix 
(GeneChip Hybridization Oven 640, GeneChip Fluidics Station 450, and 
GeneChip Scanner 7G). Microarray hybridizations were performed for each 
experimental condition using BMDMs isolated from four independent 
Nfat5+/+ or Nfat5/ mice. Microarray data analysis was performed as follows: 
the robust microarray analysis algorithm was used for background correction 
(Bolstad et al., 2003; Irizarry et al., 2003a,b), intra- and inter-microarray nor-
malization, and expression signal calculation. Once the absolute expression signal 
for each gene was calculated in each microarray, the method called significance 
analysis of microarray (Tusher et al., 2001) was applied to calculate signifi-
cant differential expression between samples providing p-values adjusted to 
multiple testing by using false discovery rate (Benjamini and Hochberg, 1995). 
A false discovery rate cutoff value of 0.1 was used for the differential expression 
results. All the analysis was done using R and Bioconductor packages. The 
microarray data are available in the Gene Expression Omnibus (GEO) database 
(http://www.ncbi.nlm.nih.gov/gds) under the accession no. GSE26343.
ChIP. BMDMs, grown in 15-cm-diameter polystyrene dishes (20–25 × 106 
cells) and stimulated with poly I:C or LPS, as indicated in figure legends, 
were fixed with 0.75% formaldehyde for 10 min at room temperature. 
Formaldehyde was then quenched with glycine (final concentration 0.26 M) 
for 5 min. After washing the plates twice with cold PBS, cells were collected 
with cell scrapers, lysed in 0.75 ml of lysis buffer (50 mM Hepes-KOH 
pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% TX-100, 0.1% sodium deoxycholate, 
0.1% SDS, 1 mM PMSF, 5 µg/ml leupeptin/aprotinin, 1 µg/ml pepstatin A, 
10 mM NaF, 10 mM sodium orthovanadate, and 10 mM -glycerophos-
phate) for 30 min on ice. Lysates were sonicated (Branson 250; Branson 
Sonic Power) for five cycles of 10 s with constant frequency and intensity 4, 
to obtain DNA fragments between 500 and 1,000 bp, and centrifuged to remove 
insoluble debris. Supernatants were collected and 5% of each sample was sepa-
rated to use as a measure of chromatin input for normalization. The rest of 
the sample was diluted 10× in dilution buffer (1% TX-100, 20 mM Tris-HCl, 
pH 8, 2 mM EDTA, 150 mM NaCl, 1 mM PMSF, 5 µg/ml leupeptin, 5 µg/ml 
aprotinin, 1 µg/ml pepstatin A, 10 mM NaF, 10 mM sodium orthovanadate, 
and 10 mM -glycerophosphate) for immunoprecipitation. Samples were 
precleared with protein A Sepharose beads (GE Healthcare) that were previ-
ously pre-adsorbed with fish sperm DNA (Roche) and bovine serum albumin 
(New England Biolabs) for 1 h at 4°C. Specific antibodies were added after 
removing the pre-clearing beads. To immunoprecipitate NFAT5, a mixture 
of two rabbit polyclonal antibodies to NFAT5 specific for its amino-terminal 
or DNA binding domain regions (López-Rodríguez et al., 1999b) was used, 
and preimmune serum served as control. To immunoprecipitate NF-B, 
Experiments in RAW 264.7 cells were done with higher doses of TLR li-
gands than those used in primary macrophages because these were required 
to induce a robust activation of the iNOS-Luc reporter and, consequently, 
high doses were also used for the rest of experiments in this cell line.
Plasmid constructs. The NFAT5-dependent reporter, ORE-Luc, was 
previously described (López-Rodríguez et al., 2001), and the iNOS-luc 
reporter (1,584 to +161 from the mouse Nos2 gene) was provided by 
S. Lamas (Centro de Investigaciones Biológica–Consejo Superior de Inves-
tigaciones Científicas, Madrid, Spain). The transfection control plasmid TK-
Renilla was from Promega. The GFP-specific shRNA in the pBSU6 vector 
was previously described (Sui et al., 2002) and the two NFAT5-specific 
shRNAs were done by inserting the following 21-nt sequences complemen-
tary to NFAT5 mRNA in pBSU6: shNFAT5-1 (shN5-1; Drews-Elger et al., 
2009), 5-GGTCAAACGACGAGATTGTGA-3, coding sequence common 
for both human and mouse NFAT5, and shNFAT5-2 (shN5-2), 5-GGCT-
GACAGCGTCCATCAACA-3, coding sequence for mouse NFAT5. Site-
directed mutagenesis of the NFAT5 binding site in the iNOS-luc reporter 
was done using the QuickChange site directed mutagenesis system of Strata-
gene according to the manufacturer’s instructions and using the following 
primers: 5-CACTTTCATAATGCTAAATTCCATGCCATG-3 (forward) 
and 5-CATGGCATGGAATTTAGCATTATGAAAGTG-3 (reverse).
Immunoblot assays. For protein detection by Western blotting, BMDMs 
were lysed in TX-100 lysis buffer (0.5–1 × 106 cells in 100–200 µl; 1% 
TX-100, 40 mM Hepes pH 7.4, 120 mM NaCl, 1 mM EDTA, 10 mM NaPPi, 
10 mM -glycerophophate, 1 mM PMSF, 5 µg/ml leupeptin, 5 µg/ml apro-
tinin and 1 µg/ml pepstatin A, 1 mM NaF, and 1 mM sodium orthovana-
date). Protein concentration in the lysates was quantified using the BCA 
assay (Thermo Fisher Scientific) to ensure loading the same amount of pro-
tein per sample in the gels. Lysates in Fig.4 D were obtained by lysing 2 × 
106 cells in 150 µl of urea lysis buffer (8 M urea, 20 mM Tris-HCl, pH 8, 
100 mM NaCl, 5 mM EDTA, 1 mM iodoacetamide, 1 mM PMSF, 5 µg/ml 
leupeptin, 5 µg/ml aprotinin, and 1 µg/ml pepstatin A). Lysates were boiled 
in reducing 1× Laemmli buffer, and 10–50 µg of total protein were sub-
jected to SDS-PAGE (PAGE) and transferred to PROTRAN (BA83; 
Schleicher & Schuell) membranes in 25 mM Tris, pH 8.4, 192 mM glycine, 
and 20% methanol. IRF3 dimers were resolved by native PAGE, as described 
previously (Iwamura et al., 2001). In brief, BMDMs were lysed in Nonidet 
P-40 lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 mM 
NaPPi, 10 mM -glycerophophate, 10 mM NaF, 10 mM sodium orthovan-
adate, 1 mM PMSF, 5 µg/ml of leupeptin/aprotinin, 1 µg/ml pepstatin A, 
and 1% Nonidet P-40). Native acrylamide gels (7.5%) were pre-run using 
25 mM Tris-HCl, pH 8.4, 192 mM glycine as cathode buffer, and 1% de-
oxycholate (DOC) as anode buffer for 30 min at 40 mA. Samples were elec-
trophoresed for 90 min at 20 mA. Gels were then transferred to PROTRAN 
membranes as indicated above. After blocking the membranes with 5% dry 
milk in TBS, the following antibodies were used: rabbit polyclonal NFAT5-
specific antibody (Affinity BioReagents) recognizes the last 17 carboxy-
terminal amino acids. Goat antibody to pyruvate kinase was from Chemicon. 
Rabbit polyclonal antibodies to iNOS and to IB, and mouse monoclonal 
antibody to -tubulin were from Santa Cruz Biotechnology, Inc. Mouse 
monoclonal antibody to IKK was from Imgenex. Mouse monoclonal anti-
bodies to phospho-p38 (pT180/pY182), to phospho-ERK1/2 (pT202/pY204), 
and to phospho-JNK/SAPK (pT183/pY185) were from BD. Rabbit poly-
clonal antibody to phospho-MAPKAPK-2 (pT222) was from Cell Signaling 
Technology. Rabbit polyclonal antibody to IRF3 was from Invitrogen. The 
antibody to goat IgG coupled to HRP was from Dako, and the antibody to 
mouse IgG and to rabbit IgG coupled to HRP were from GE Healthcare. 
Protein bands were visualized by enhanced chemiluminescence, using 
Supersignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
Flow cytometry. 2 × 105 cells were blocked for 20 min in 1× PBS con-
taining 10% FBS, 0.1% sodium azide, and 0.2 µg of an antibody to the Fc 
receptor (BD). Cells were then incubated with surface marker-specific anti-
bodies in the same solution (1 µg of antibody for 106 cells) and analyzed with 
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an antibody to p65 (Santa Cruz Biotechnology, Inc.) was used and normal 
rabbit IgG (Santa Cruz Biotechnology, Inc.) was included as a control. 
Antibodies were then added to the lysates and incubated overnight at 4°C. 
Pre-adsorbed protein A Sepharose beads were then added, incubated for 1 h 
at 4°C, and then washed three times with washing buffer (0.1% SDS, 1% 
TX-100, 20 mM Tris-HCl, pH 8, 2 mM EDTA, and 150 mM NaCl) and 
once with final washing buffer (0.1% SDS, 1% TX-100, 20 mM Tris-HCl 
pH 8, 2 mM EDTA, and 500 mM NaCl). To elute the DNA, beads were 
incubated with elution buffer (1% SDS and 100 mM NaHCO3) for 15 min 
at room temperature. To reverse the cross-linking, samples were incubated 
overnight at 65°C with 6 ng/µl RNase (Roche) and DNA was purified 
using the QIAGEN PCR purification system. DNA was then subjected to 
RT-qPCR using the primers described in Table S2. Immunoprecipitated 
DNA from each sample was normalized to its respective chromatin input.
Cytokine production. Supernatants from the same cultures (2 × 106 cells 
in 3 ml of media) from which RNA was processed were harvested and TNF 
and IL-6 were measured by ELISA (R&D Systems) with an Opsys MR plate 
reader (Dynex Technologies).
Statistical analysis. Statistical significance of the experimental data were 
determined by the paired Student’s t test.
Online supplemental material. Fig. S1 shows the induction of a group of 
poly I:C–induced genes in NFAT5-deficient macrophages, and also shows 
the effect of NFAT5 in the expression of iNOS/Nos2 in macrophages stim-
ulated with the combination of LPS plus IFN-. Fig. S2 shows that macro-
phages isolated from the BM of NFAT5-deficient mice differentiate normally 
and display normal activation of the major signaling pathways downstream 
TLRs. Fig. S3 shows that in vitro differentiation and TLR-mediated activa-
tion of macrophages do not cause an osmotic stress response. Fig. S4 illus-
trates the potential binding sites for NFAT5 in various target genes, and 
shows its association with a group of targets upon poly I:C stimulation of 
macrophages. Fig. S5 displays controls for the effect of IKK deletion in 
macrophages, and also shows the expression of Tnf and Nos2 in response to 
LPS in NFAT5-deficient macrophages pretreated with CHX. Table S1 lists 
genes that are differentially expressed between LPS-treated control and 
NFAT5-deficient BMDMs. Table S2 includes a list of the primers used 
in this study. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20111569/DC1.
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